Celator Pharmaceuticals today announced positive results from preclinical studies to evaluate the optimal ratio of irinotecan and cisplatin to deliver synergistic benefit against a range of tumor cell lines in vitro.
Picosun Oy, Finland has entered into a demonstration agreement with Nagoya University, Japan. Professor Zaima's laboratory at Nagoya University has recently purchased a SUNALE R-150B ALD reactor manufactured by Picosun.
ThalesNano Inc. and ETH Zurich, ThalesNano today announced collaboration with the Swiss Federal Institute of Technology Zurich (ETH Zurich) on flow chemistry applications. The agreement will focus on the application of chemistries and technologies utilizing ThalesNano's products to solve difficult chemistry applications.
Nanostellar, Inc. reported today that its Rational Catalyst Design process has enabled it to significantly reduce research and development time for new diesel-emissions catalysts, a major factor in its recent announcement of NS Gold, the first catalyst that uses gold to improve the performance and reduce the cost of diesel automobile catalytic converters.
NaturalNano, Inc., a developer of advanced nanomaterials and additive technologies, today announced that Pleximer-N, a new nylon-based additive product, has completed final manufacturing-scale validation and is available for purchase.
IDGLOBAL has developed its Nano-Molecular Markers to be easily and seamlessly applied to the wine bottle or label for the purpose of tracking, protecting and controlling counterfeiting infections that are plaguing the collector and vintage wine industry worldwide at an alarming rate.
Pioneer Surgical Technology today announced its acquisition of Angstrom Medica, Inc., headquartered in Woburn, MA. Angstrom is the first company to obtain FDA approval for a nanotechnology device - NanOss.
Arrowhead Research Corporation announced today that it has provided $2.4 million in additional capital to wholly-owned subsidiary, Tego Biosciences Corporation. Tego is developing and commercializing therapeutics and other products based on the antioxidant properties of modified fullerenes.
DuPont today announced an alliance with Canada-based Morph Technologies Inc., Integran Technologies Inc., and U.S.-based PowerMetal Technologies to develop and commercialize a nanocrystalline metal/polymer hybrid technology that will be used to manufacture extremely lightweight components with the strength and stiffness of metal and the design flexibility and lightweight benefits of high-performance thermoplastics.
Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced study results that demonstrated the company's TargeTran delivery system is capable of delivering vascular endothelial growth factor (VEGF) targeted small interfering RNAs (siRNAs) that suppress tumor-induced angiogenesis by silencing target gene expression in mice.
The Nano Science and Technology Institute (NSTI) is pleased to announce that abstracts are being accepted for the Merck Corporate Symposium: Targeted Delivery of siRNA, to be held during Nanotech 2008 in Boston, MA.
Nano-Proprietary, Inc. announced that its subsidiary, Applied Nanotech, Inc. (ANI), has been awarded an SBIR Phase II contract for the continued development of a "Carbon Nanotube (CNT)-Based Gas Ionizer to Replace Radioactive Sources" from the Homeland Security Advanced Research Project Agency (HSARPA).
API Nanotronics Corp., a leading supplier of electronic components and nanotechnology research and development to the defense and communications sectors, today announced the introduction of a new line of proprietary UV polarizers.
Nano Chemical Systems Holdings, Inc. announces the completion of the sale of SeaSpray Aerosol one of the Company's wholly owned subsidiaries. SeaSpray was sold in exchange for the forgiveness of $1,330,000 in debt.